X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis

J Pediatr Hematol Oncol. 2017 Nov;39(8):e483-e485. doi: 10.1097/MPH.0000000000000938.

Abstract

Hemophagocytic lymphohistiocytosis is characterized by uncontrolled activation of the immune system that leads to systemic hyperinflammation. Lymphoproliferative syndrome linked to the X chromosome is a hereditary immunodeficiency characterized by an inability to mount an adequate immune response to an Epstein-Barr virus infection. Hemophagocytic lymphohistiocytosis is one of the main clinical features of X-linked lymphoproliferative syndrome. We report the case of a patient who presented with primary hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection without a familial history of immunodeficiency. A mutation in the SH2D1A gene was identified, which confirmed the diagnosis of type 1 X-linked lymphoproliferative syndrome.

Publication types

  • Case Reports

MeSH terms

  • Amino Acid Substitution
  • Biomarkers
  • Biopsy
  • Child
  • Codon
  • DNA Mutational Analysis
  • Epstein-Barr Virus Infections / complications
  • Herpesvirus 4, Human
  • Humans
  • Immunophenotyping
  • Lymphohistiocytosis, Hemophagocytic / diagnosis*
  • Lymphohistiocytosis, Hemophagocytic / etiology*
  • Lymphoproliferative Disorders / diagnosis*
  • Lymphoproliferative Disorders / etiology*
  • Male
  • Multimodal Imaging
  • Mutation*
  • Phenotype
  • Signaling Lymphocytic Activation Molecule Associated Protein / genetics*

Substances

  • Biomarkers
  • Codon
  • Signaling Lymphocytic Activation Molecule Associated Protein